On August 9, Zhejiang Nuohui Health Technology Co., Ltd. (hereinafter referred to as “Nuohui Health”) has completed the US$20 million Series B financing. This round of financing was led by Qiming Venture Capital, Junlian Capital, Softbank China, Purdue Technology And so on.

Prior to this, in June 2013 and August 2014, Nuohui Health introduced two rounds of angel investment respectively. In December 2015, Nuohui Health received a total of 20 million US dollars of investment in Junlian Capital and Softbank China Capital. In addition, in June 2013, the company also obtained the A5 million venture capital support fund of the Binjiang 5050 Plan.

Founded in January 2013 and headquartered in Hangzhou, Nuohui Health is an innovative biotech company focused on early screening and testing services for high-risk cancer in China. Nuohui Health hopes to combine genetic testing and molecular diagnostic technology to build a home health self-management system with early cancer screening as the core through Internet application and big data platform, to achieve early diagnosis and treatment of high-risk cancer nationwide, and effectively reduce Cancer mortality and incidence, so as to rationally improve the structure of medical costs, to achieve the goal of saving overall medical costs.

At present, Nuohui Health mainly focuses on digestive tract tumors, allowing users to complete early screening of cancer in their home scenes. It has launched three digestive tract related products: Chang Weiqing, Chang Weining and Chang Weiming. Intestinal feces, which detect three target genes related to intestinal cancer in three indicators, thereby judging whether a person's intestine has a problem.

By analyzing the genetic material in the feces (fecal DNA), Changweiqing can detect advanced adenomas and intestinal cancer lesions with a diameter of 1 cm or more, and detect early intestinal cancer gene mutations in time, so that intestinal cancer is found 5 years earlier than the hospital diagnosis. . According to Zhu Yeqing, CEO of Nuohui Health Co-founder, this method can screen tumors earlier than liquid biopsy, and precancerous lesions are found 5 years earlier than conventional blood cancer indicators.

In 2017, Nuohui Health launched a new high-risk Helicobacter pylori virulence factor testing service for gastric cancer--Chang Weining and high-risk joint detection service for intestinal cancer-Chang Weiming. Compared with Chang Weining, the current hospital generally uses the method of “blowing method” to detect antibodies. Indirect detection of Helicobacter pylori, this test can only give the judgment of “Yes” or “None”. In addition, it may be due to Other bacteria also produce interference with the same antibodies, causing false positives and producing false positive results.

Chang Weining directly detects H. pylori by genetic testing of feces, not only can determine the presence or absence of H. pylori, but also can be used for strain typing, identify high-risk groups for the characteristics of Chinese population, and will not be affected by other bacteria. interference.

Zhu Yeqing said that screening for gastric cancer belongs to the detection of gastric cancer carcinogenic factor-Helicobacter pylori and typing, which is a risk screening for gastric cancer and is not a diagnosis.

At the level of market operation, Nuohui Health uses a combination of online and offline methods to promote and promote. Online, Nuohui Health has established business partnerships with a number of medical institutions and insurance companies, including Aikang Guobin, Wanxinhe, PICC Health, Taikang Insurance, Zhongan Insurance, and Xincheng Life Insurance. Online, Nuohui Health cooperates with Internet medical companies such as Micro Medical Network, Almond Doctor and Health 160.

At present, Nuohui Health has two research and development centers in Hangzhou and Beijing, as well as Beijing Nuoan Medical Laboratory and Hangzhou Nuokang Medical Laboratory. In terms of market, Nuohui Health mainly cooperates with insurance companies, medical examinations, hospitals, and mobile medical platforms to expand the market. At present, nearly 50,000 users have completed gastrointestinal testing, of which about 80% are paid users.

Vitamins Powder

Vitamins: Various trace organic substances essential for the nutrition of most animals and some plants, especially as coenzymes and coenzyme precursors, which play a role in regulating metabolic processes, but they do not provide energy or serve as building blocks. Vitamins are found in natural foods or are sometimes produced in the human body.
Vitamins are tiny molecules needed to keep the body functioning properly (vitamin B12 is the largest vitamin molecule, with a molecular weight of 1,355). In the article How sunburns and tans are formed, we learned that the body can make its own vitamin D, but usually the vitamin must be supplied through food.

Vitamins Powder,Vitamin C Powder,Biotin Powder,Vitamin E Powder

Shaanxi Zhongyi Kangjian Biotechnology Co.,Ltd , https://www.zyplantextract.com